Clinical and Molecular Evaluation of Inborn Errors of Immunity in a tertiary care centre of North In
33/29-1/2019-TF/Rare/BMS
ICMR
March 1, 2021
Feb. 29, 2024
Three Year
Inborn Errors
None
None
To evaluate patients with early-onset immune-dysregulation (hemophagocytic lymphohistiocytosis, severe hematological autoimmunity, early-onset inflammatory bowel disease, benign lymphoproliferation fo
Immunodysregulation; Next Generation Sequencing; Flow Cytometry; Lymphoproliferation; Immunogenetics
None
49,99,450/-
Dr. Amit Rawat/None/Department of pediatrics PGIMER, Chandigarh